| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |